Robert Andrew Douglas - 14 Oct 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
President and COO
Signature
Robert Douglas, President and Chief Operating Officer, ResMed Inc.
Issuer symbol
RMD
Transactions as of
14 Oct 2022
Transactions value $
-$1,392,056
Form type
4
Filing time
17 Oct 2022, 19:25:34
Previous filing
16 Sep 2022
Next filing
15 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Options Exercise $66.7K +1.15K +4.03% $58.24 29.6K 14 Oct 2022 Direct F1
transaction RMD ResMed Common Stock Options Exercise $984K +16.9K +57.14% $58.24 46.4K 14 Oct 2022 Direct F1
transaction RMD ResMed Common Stock Sale -$2.44M -11.4K -24.45% $215.09 35.1K 14 Oct 2022 Direct F1, F2
holding RMD ResMed Common Stock 228K 14 Oct 2022 Douglas Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -1.15K -3.17% $0.00 34.9K 14 Oct 2022 ResMed Common Stock 1.15K $58.24 Direct F3
transaction RMD ResMed Common Stock Options Options Exercise $0 -16.9K -48.36% $0.00 18K 14 Oct 2022 ResMed Common Stock 16.9K $58.24 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 This transaction was executed in multiple trades at prices ranging from $213.62 to $217.36. The price reported above reflects the weighted average sale price.
F3 Represents date options first became exercisable. Options vest 1/3 per year.